Abstract

Herpes simplex virus 1 (HSV-1) is a prevalent human pathogen that can target skin to establish infection in the epithelium. Since the human skin provides effective barriers against pathogens under normal conditions, HSV-1 must find opportunistic pathways in order to penetrate the skin and initiate infection. As mechanical wounds of the human skin surface do not provide ad hoc entry portals for HSV-1, we explored the role of pathological skin conditions. Ex vivo infection studies revealed successful invasion in lesional AD skin implying that the virus can overcome both the stratum corneum and the tight junction barriers. To dissect the parameters that contribute to HSV-1 invasion, we treated human skin without pre-existing barrier defects with interleukin (IL)-4 and IL-13 to investigate whether Th2 cytokine-driven inflammation already induces modifications that allow viral penetration. Strikingly, we detected infected cells in the epidermis indicating that the IL-induced, AD-like skin phenotype can indeed facilitate HSV-1 invasion. Potential modifications allowing for facilitated viral access include impaired tight junctions, an altered stratum corneum, or a redistribution of the HSV-1 receptor nectin-1. Studies using human epidermal equivalents highlighted the importance of functional tight junctions in addition to the stratum corneum in restricting HSV-1 entry and provide a tool to mimic the pathological alterations in AD skin that allow HSV-1 invasion.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.